Form D · Other Health Care

Arterys Inc

San Francisco, CA · CIK 0001658136

Offering snapshot reported May 12, 2020 · SEC filing

Reported sold
$24.4M
Offering amount: $27.5M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 28, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 12, 2020Initial$24,386,818No comparison15SEC filing
Nov 17, 2017Initial$30,062,157No comparison24SEC filing
Dec 10, 2015Initial$7,135,937No comparison23SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-366720
Sale of Series C Preferred Stock, Series C-1 Preferred Stock and Common Stock issuable upon conversion. $9,402,613.39 of the Total Amount Sold was conversion of outstanding debt.

Source: Form D, filed May 12, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Axerio Cilies Director, Executive
Fabien Beckers Director, Executive
Robert Brownell Director
Steve Dow Director
Tim Henn Executive
Khush Mehta Director
Dave Rosa Director
David Rosa Director
Henry Weinstein Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
51 Federal Street Suite 305
San Francisco, CA, 94107